EU-Zulassung für Rituximab-Biosimilar
Crossref DOI link: https://doi.org/10.1007/s15004-017-5645-4
Published Online: 2017-03-17
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
red,
